Competitive Intelligence
- medicinal data is scattered in multiple EU/BE sources (RIZIV, FAGG, EMA)
- manually following up changes takes up too many resources and time
- reconstructing years of reimbursement and approval history feels like searching for a needle in a haystack
- changes are easily missed in larger competitive landscapes
- reconstructing the landscape for new acquisitions requires a large effort
How pharma benefits from our solutions
- follow medicinal landscape of assets and competitors relevant to their business units
- instantly receive up-to-date datasheets (e.g. Excel) with chronological changes in
- approvals
- launches and stops
- start dates of reimbursement by paragraph
- track changes in legislative paragraph texts
- prices
- instantly retrieve over 10 years of historical data instead of manually sifting through stacks of reference files
For many people, it helps to see a live demo of concrete solutions. Book a free 30 minute online meeting to see what solutions have worked for other customers.
Questions? Contact us via info@digile.be.